X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2453) 2453
Publication (127) 127
Book Chapter (20) 20
Book Review (20) 20
Conference Proceeding (11) 11
Dissertation (6) 6
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
desferrioxamine (1903) 1903
humans (954) 954
iron (646) 646
animals (634) 634
male (625) 625
deferoxamine (536) 536
index medicus (459) 459
female (436) 436
biochemistry & molecular biology (404) 404
deferoxamine - pharmacology (385) 385
deferoxamine - therapeutic use (326) 326
hematology (317) 317
iron - metabolism (317) 317
adult (289) 289
rats (288) 288
deferiprone (279) 279
pharmacology & pharmacy (224) 224
thalassemia (221) 221
iron chelating agents - therapeutic use (218) 218
iron chelating agents - pharmacology (215) 215
adolescent (210) 210
beta-thalassemia (208) 208
iron overload (208) 208
mice (200) 200
desferrioxamine-b (197) 197
overload (180) 180
deferoxamine - administration & dosage (170) 170
child (168) 168
toxicity (166) 166
oxidative stress (165) 165
therapy (160) 160
thalassemia major (149) 149
lipid-peroxidation (148) 148
middle aged (148) 148
ferritins - blood (136) 136
free radicals (133) 133
pyridones - therapeutic use (129) 129
iron chelators (127) 127
deferoxamine - adverse effects (126) 126
ferritin (124) 124
chelation therapy (123) 123
aluminum (122) 122
chelation (120) 120
iron overload - drug therapy (120) 120
beta-thalassemia - drug therapy (118) 118
inhibition (112) 112
analysis (110) 110
iron chelation (110) 110
desferrioxamine b (105) 105
oncology (104) 104
toxicology (103) 103
dose-response relationship, drug (101) 101
kinetics (99) 99
siderophores (98) 98
cells (97) 97
iron - blood (95) 95
chemistry, inorganic & nuclear (92) 92
growth (92) 92
urology & nephrology (91) 91
disease (90) 90
iron chelating agents - administration & dosage (90) 90
aged (89) 89
beta-thalassemia - complications (89) 89
deferasirox (88) 88
deferoxamine - chemistry (88) 88
transferrin (88) 88
pediatrics (86) 86
cells, cultured (84) 84
endocrinology & metabolism (83) 83
transfusion reaction (83) 83
microbiology (81) 81
rats, sprague-dawley (80) 80
rats, wistar (80) 80
iron chelating agents - chemistry (79) 79
oxidation-reduction (79) 79
survival (79) 79
time factors (79) 79
treatment outcome (79) 79
ligands (76) 76
liver - metabolism (76) 76
chelating agents - pharmacology (75) 75
siderophore (74) 74
child, preschool (73) 73
disease models, animal (73) 73
iron chelating agents - adverse effects (73) 73
drug therapy, combination (72) 72
iron overload - etiology (72) 72
liver (72) 72
neurosciences (72) 72
cell biology (71) 71
chemistry, multidisciplinary (71) 71
beta-thalassemia - therapy (70) 70
expression (70) 70
biophysics (69) 69
blood transfusion (68) 68
superoxide (68) 68
apoptosis (67) 67
pyridones - pharmacology (67) 67
beta-thalassemia major (66) 66
chelation-therapy (66) 66
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2385) 2385
German (20) 20
Spanish (17) 17
French (15) 15
Japanese (15) 15
Italian (7) 7
Chinese (6) 6
Korean (6) 6
Portuguese (3) 3
Turkish (2) 2
Czech (1) 1
Persian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chemistry – A European Journal, ISSN 0947-6539, 10/2018, Volume 24, Issue 60, pp. 15938 - 15938
True lords of the rings are NRPS‐independent siderophore (NIS; NRPS=nonribosomal peptide synthetase) synthetases (depicted as a protein surface representation)... 
avaroferrin | iterativity | NIS | desferrioxamine | siderophore biosynthesis
Journal Article
BBA - General Subjects, ISSN 0304-4165, 03/2018, Volume 1862, Issue 3, pp. 761 - 774
The cyclin-dependent kinase inhibitor, p21, is well known for its role in cell cycle arrest. Novel anti-cancer agents that deplete iron pools demonstrate... 
Desferrioxamine | Iron chelator | p21 | Dp44mT
Journal Article
Free Radical Biology & Medicine, ISSN 0891-5849, 02/2000, Volume 28, Issue 4, pp. 652 - 656
People with diabetes are prone to develop peripheral vascular and nerve abnormalities which, in extreme cases, can lead to limb amputations. Although numerous... 
desferrioxamine
Journal Article
ORGANIC & BIOMOLECULAR CHEMISTRY, ISSN 1477-0520, 07/2019, Volume 17, Issue 28, pp. 6866 - 6871
The bifunctional ligand p-SCN-Bn-HOPO, which has four 1,2-hydroxypyridinone groups on a spermine backbone with an isothiocyanate linker, has been shown to be... 
CHEMISTRY, ORGANIC | DESFERRIOXAMINE | ZR-89 | ZIRCONIUM-89 | COMPLEXATION | RATIONAL DESIGN
Journal Article
JOURNAL OF MEDICINAL CHEMISTRY, ISSN 0022-2623, 06/2014, Volume 57, Issue 11, pp. 4849 - 4860
Zirconium-89 is an effective radionuclide for antibody-based positron emission tomography (PET) imaging because its physical half-life (78.41 h) matches the... 
CHEMISTRY, MEDICINAL | POSITRON-EMISSION-TOMOGRAPHY | IMMUNO-PET | BEARING NUDE-MICE | DISCRETE 8-COORDINATION | IN-VIVO | ZR-89-TRASTUZUMAB | AGENTS | DESFERRIOXAMINE | MONOCLONAL-ANTIBODIES | CANCER
Journal Article
Journal of Neuroscience Research, ISSN 0360-4012, 09/1999, Volume 57, Issue 5, pp. 735 - 739
We combined the use of desferrioxamine as an iron chelator, microdialysis sampling, and iron analysis by atomic absorption spectroscopy to measure... 
desferrioxamine
Journal Article
Chemical Science, ISSN 2041-6520, 2017, Volume 8, Issue 3, pp. 2309 - 2314
We report our initial investigations into the use of tetraazamacrocycles as zirconium-89 chelators. We describe the synthesis and complete characterization of... 
RADIATION-DOSIMETRY | ANTIBODIES | HYDROXAMATE LIGANDS | DESIGN | THERAPY | CHEMISTRY | CHELATOR | DESFERRIOXAMINE | ZR-89 | CHEMISTRY, MULTIDISCIPLINARY | PET
Journal Article
OnLine Journal of Biological Sciences, 2018, Volume 18, Issue 1, pp. 108 - 114
Journal Article
Coordination Chemistry Reviews, ISSN 0010-8545, 2002, Volume 228, Issue 2, pp. 97 - 113
Acute Al toxicity is not common. Toxicity from prolonged Al exposure has become much less common, but still occurs occasionally. The potential contribution of... 
Chelators | Desferrioxamine | Hydroxypyridinone | Aluminum | BONE-DISEASE | ALZHEIMERS-DISEASE | IMMOBILIZED DESFERRIOXAMINE | hydroxypyridinone | LOADED UREMIC RATS | aluminum | chelators | MOBILIZING ACTIONS | CHEMISTRY, INORGANIC & NUCLEAR | INDUCED NEUROFIBRILLARY DEGENERATION | IN-VITRO | desferrioxamine | HEMODIALYSIS-PATIENTS | IRON CHELATOR | LOW-DOSE DESFERRIOXAMINE
Journal Article
Chemical Society Reviews, ISSN 0306-0012, 12/2013, Volume 43, Issue 1, pp. 26 - 29
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 04/2017, Volume 27, Issue 8, pp. 1698 - 1704
Methyl-substituted adamantyl groups were highly ranked from a library of polycyclic cage-based ancillary units that when grafted onto the amine group of the... 
Iron chelators | Desferrioxamine B | Polycyclic cage compounds | Parkinson’s disease
Journal Article
Chemical communications (Cambridge, England), ISSN 1359-7345, 08/2018, Volume 54, Issue 70, pp. 9813 - 9816
An analogue of the bacterial siderophore desferrioxamine B (DFOB) containing a disulfide motif in the backbone was produced from Streptomyces pilosus cultures... 
Journal Article
by Liu, J and Liu, W and Liu, Y and Miao, Y and Guo, YF and Song, HY and Wang, FD and Zhou, HY and Ganz, T and Yan, B and Liu, SJ
HAEMATOLOGICA, ISSN 0390-6078, 08/2019, Volume 104, Issue 9, pp. 1768 - 1781
Genetic iron-overload disorders, mainly hereditary hemochromatosis and untransfused beta-thalassernia, affect a large population worldwide. The primary... 
MINIHEPCIDINS | HEPATIC HEPCIDIN EXPRESSION | TMPRSS6 | HFE | MICE | ANEMIA | DESFERRIOXAMINE | IDENTIFICATION | HEMATOLOGY | ERYTHROID REGULATOR | MURINE | Index Medicus
Journal Article
Chemical Society reviews, ISSN 0306-0012, 01/2014, Volume 43, Issue 1, pp. 260 - 290
Journal Article